PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW124069View Pathway |
signaling
chebulagic acid Metabolism 1559277983 1589861306 1597248631Homo sapiens
|
Creator: Guest: Anonymous Created On: August 12, 2020 at 10:10 Last Updated: August 12, 2020 at 10:10 |
PW124042View Pathway |
signaling
chebulagic acid Metabolism 1559277983 1596798296Homo sapiens
|
Creator: Guest: Anonymous Created On: August 07, 2020 at 05:05 Last Updated: August 07, 2020 at 05:05 |
PW123794View Pathway |
signaling
chebulagic acid Metabolism 1581167212Homo sapiens
|
Creator: Guest: Anonymous Created On: February 08, 2020 at 06:07 Last Updated: February 08, 2020 at 06:07 |
PW123807View Pathway |
signaling
chebulagic acid Metabolism 1581839290Homo sapiens
|
Creator: Guest: Anonymous Created On: February 16, 2020 at 00:48 Last Updated: February 16, 2020 at 00:48 |
PW123825View Pathway |
signaling
chebulagic acid Metabolism 1582757459Homo sapiens
|
Creator: Guest: Anonymous Created On: February 26, 2020 at 15:51 Last Updated: February 26, 2020 at 15:51 |
PW124219View Pathway |
physiological
chebulagic acid Metabolism 1602639807Homo sapiens
|
Creator: Guest: Anonymous Created On: October 13, 2020 at 19:43 Last Updated: October 13, 2020 at 19:43 |
PW124232View Pathway |
chebulagic acid Metabolism 1602980507Homo sapiens
|
Creator: Guest: Anonymous Created On: October 17, 2020 at 18:21 Last Updated: October 17, 2020 at 18:21 |
PW124234View Pathway |
chebulagic acid Metabolism 1602981862Homo sapiens
|
Creator: Guest: Anonymous Created On: October 17, 2020 at 18:44 Last Updated: October 17, 2020 at 18:44 |
PW128386View Pathway |
drug action
Dolasetron Serotonin antagonist Action PathwayHomo sapiens
Dolasetron is a selective serotonin 5-HT3 receptor antagonist. In vivo, the drug is rapidly converted into its major active metabolite, hydrodolasetron, which seems to be largely responsible for the drug's pharmacological activity. The antiemetic activity of the drug is brought about through the inhibition of 5-HT3 receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT3 receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone.
|
Creator: Omolola Created On: August 25, 2023 at 12:02 Last Updated: August 25, 2023 at 12:02 |
PW128196View Pathway |
drug action
Donepezil Acetylcholinesterase Inhibitor Action PathwayHomo sapiens
Donepezil is an acetylcholinesterase inhibitor that is used in the treatment of Alzheimer's Disease and dementia. It is administered orally or transdermally, sometimes in combination with memantine in order to treat moderate to severe dementia. Donepezil selectively inhibits the acetylcholinesterase enzyme, by doing so it is believed to enhance cholinergic transmission to relieve the symptoms of Alzheimer and dementia.
|
Creator: Anaya Created On: August 01, 2023 at 11:50 Last Updated: August 01, 2023 at 11:50 |